|
|
|
|
|
|
|
|
|
|
|
07.07.25 - 18:57
|
Piper Sandler Mourns the Loss of Board Member Sherry Smith (Business Wire)
|
|
MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR) is deeply saddened to announce the unexpected passing of Sherry Smith, a valued and respected member of our board of directors.
Sherry served as a director of Piper Sandler since 2016 and was a dedicated and insightful leader, who brought a wealth of experience, financial expertise, and unwavering integrity to the firm. Her contributions over the years were incredibly helpful during a period of significant growth. She served as chairperson of the Audit Committee.
“Sherry was an outstanding director and an even better person,” said Chad Abraham, chairman and chief executive officer of Piper Sandler. “She provided steady leadership, sound judgment, and a deep sense of purpose in every board discussion. Her loss is profoundly felt by all of us, and we will miss her tremendously.”
“Sherry brought humility, clarity, and insight to every meeting that she was involved in. She had a unique ability to listen deeply, ask the right question...
|
|
|
|
|
30.06.25 - 15:48
|
Piper Sandler Strengthens Private Capital Advisory Team with Addition of Andy Nick as Co-Head of Secondary Capital Advisory (Business Wire)
|
|
NEW YORK--(BUSINESS WIRE)--$PIPR--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Andy Nick as managing director and co-head of secondary capital advisory within the private capital advisory group. Nick will work closely with private equity clients to provide bespoke liquidity and capital solutions, including GP-led continuation funds, fund recapitalizations, and LP portfolio transactions.
“Andy is a highly respected advisor with deep relationships across the private equity ecosystem and has a strong track record of delivering thoughtful, strategic secondary solutions. His addition reflects our continued investment in the private markets and enhances our ability to serve clients across the full lifecycle of fund management, specifically as it relates to our GP continuation vehicle capabilities,” said Ryan Schlitt, global head of private capital advisory at Piper Sandler.
Nick brings over 20 years of experience in private capital markets, with a f...
|
|
|
25.06.25 - 17:03
|
OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium (GlobeNewswire EN)
|
|
MIAMI, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) today announced its participation in the 3rd Annual Piper Sandler Obesity Symposium being held virtually on June 26, 2025. Management will be participating in a fireside discussion moderated by Edward Tentoff, Managing Director, Senior Biotechnology Analyst. Investors can register for the symposium by contacting their Piper Sandler representative....
|
|
25.06.25 - 16:42
|
Piper Sandler Expands Biotechnology Equity Research Team with the Addition of Kelsey Goodwin (Business Wire)
|
|
NEW YORK--(BUSINESS WIRE)--$PIPR--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Kelsey Goodwin as a director and senior research analyst to the biotechnology equity research team. Goodwin will be based in the Boston office with coverage responsibilities of oncology.
“We are excited to welcome Kelsey to the Piper Sandler platform. She brings a deep understanding and passion for our industry and builds strong relationships to serve clients. We are deeply committed to the biotechnology sector and Kelsey's addition will only strengthen our industry leading biopharma research practice that is collaborative and energized to provide insights for our clients,” said Michael Cox, co-head of global equities at Piper Sandler.
Prior to joining Piper Sandler, Goodwin spent seven years at Guggenheim, where she focused primarily on the oncology therapeutic area. Before Guggenheim, Kelsey worked in pharmaceutical strategy consulting for three years. Goodwin re...
|
|
|
|